Market Brief
Compare MarketsSide-by-side comparison across 2–5 markets.Global Value DossierHTA pathways, pricing corridors, and evidence requirements by market.Pricing & Evidence SimulatorModel conservative, base, and optimistic reimbursement outcomes across markets.Regulatory TrackerMonitor regulatory and market changes across your target markets, updated quarterly.
MatchEnterprisePricing
Get Started
Enterprise

Full market entry support.

Built for BD and market access teams entering multiple markets or a major new geography. Vantro Enterprise combines full platform access with vetted consultant connections and direct advisory support, so your team has the right market data, the right people on the ground, and the strategic backing to move fast.

Get in touch →See how it works
What’s included

Platform, execution, and strategy. Together.

Intelligence
The full platform
Unlimited market briefs, Compare Markets, Global Value Dossier, Pricing & Evidence Simulator, Pricing Scenarios, and Regulatory Tracker. Team access included.
Execution
Vetted in-country experts
We connect you with regulatory advisors, market access specialists, and distribution partners from our vetted roster, matched to your product and markets.
Strategy
Market entry advisory
Discovery call, brief review, market entry sequencing, and ongoing check-ins, grounded in 10+ years of practice across WHO, World Bank, and UNICEF.
Process

How it works.

01
Discovery call
30 minutes. We understand your product, target markets, and timeline.
02
We build your first brief together
Full platform output for your priority market. We review every citation and walk you through the findings.
03
We match you with the right experts
Regulatory, market access, or distribution; we make the introduction. Engagement terms are agreed directly between you and the expert.
04
Ongoing support
Quarterly regulatory tracker updates, scenario planning as your strategy evolves, and direct access to our team.
Who it’s for

Built for teams entering new markets seriously.

  • —Mid-size biotech, specialty pharma, and medtech companies with CE Mark or FDA clearance evaluating international expansion
  • —BD and market access leads who need structured intelligence and in-country execution support
  • —Companies entering 3 or more markets simultaneously
  • —Teams without in-house market entry expertise for every geography
  • —Companies that have been quoted $20–40K per market by consultants and need a better option
  • —Organisations preparing for a launch in Africa, Asia, MENA, or Latin America
Track record

The practice behind the platform.

Built on direct client work across pharma, medtech, and multilateral health.

Global pharma manufacturer
Vaccine access · 6 markets
PHARMA
PharmaAfrica · AsiaImmunisation
Mapped market entry across six emerging economies, aligning registration timing to UNICEF and GAVI procurement cycles and structuring a blended commercialisation model across public and private channels.
Procurement timing and regulatory strategy are the same decision.
MedTech manufacturer
Diagnostics · Sub-Saharan Africa
MEDTECH
KENGZA
MedTechSub-Saharan AfricaDiagnostics
Sequenced entry across Kenya, Nigeria, and South Africa. Private channel dynamics outperformed public tender projections in the lead market. Parallel submission compressed the window without adding compliance risk.
On-paper market rankings misread real commercial viability.
Intergovernmental organisation
AI strategy · Emergency operations
MULTILATERAL
123
Digital HealthGlobalHumanitarian
Assessed strategic readiness: identified a data infrastructure gap and modelled three costed investment scenarios, benchmarked against six peer emergency centres globally.
Strategy without infrastructure mapping creates roadmaps that don't execute.
Multilateral development bank
Health financing · South Asia
DEVELOPMENT
StrategySouth AsiaHealth Financing
Supported health financing and primary care strategy for a South Asian market, synthesising system performance data, financing trends, and implementation capacity aligned to national health priorities.
Financing structures determine what gets procured and when.
Anonymized engagements.

Get in touch.

Tell us about your product and markets. We'll be in touch within 2 business days.